This menu provides the list of EV mRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
UniProt accession
UniProt name
mRNA name
Gene symbol
Species
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
In vitro/In vivo
In vitro
In vivo
By sample type
Colorectal adenocarcinoma (SW480)
Ewing's sarcoma cell (A673)
Ewing's sarcoma cell (SB-KMS-KS1)
Ewing's sarcoma cell (SK-N-MC)
Serum
By sample status
Normal
Patients of glioblastoma
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent mRNA accidently have higher intensity than that mRNA.
- TPR is the percentile of mRNA among the present mRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same mRNA can have several FPR and TPR values.
mRNA name
UniProt accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
Histone H3
B2R4P9
0.0e+0
2.5e-1
Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells.
BMC Genomics. 2009 Nov 25;10:556. doi: 10.1186/1471-2164-10-556.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
9.2e-2
Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells.
BMC Genomics. 2009 Nov 25;10:556. doi: 10.1186/1471-2164-10-556.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
1.8e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
2.6e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
1.3e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
1.6e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
3.1e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
4.1e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
4.0e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
2.9e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
3.7e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
2.0e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
2.6e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
4.1e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
4.6e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
4.6e-1
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
2.3e-1
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
2.5e-1
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
3.8e-1
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
3.0e-1
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
1.9e-1
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
2.0e-1
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
3.1e-1
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
3.7e-1
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
1.9e-1
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
2.1e-1
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
1.9e-1
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
2.3e-1
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
COG2036
31
/
0
/
31
Histone H3
B2R4P9
0.0e+0
3.1e-1
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.
COG2036
31
/
0
/
31
[1]